480 related articles for article (PubMed ID: 1384948)
61. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
Maruyama S
Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
[TBL] [Abstract][Full Text] [Related]
62. Effects of lymph node stromal cells on the differentiation of a cell line established from an atypical prolymphocytic leukemia with phenotypes of both chronic lymphocytic and hairy cell leukemias.
Takeuchi H; Amano Y; Katayama I
Leuk Lymphoma; 1994; 14 Suppl 1():49-56. PubMed ID: 7820053
[TBL] [Abstract][Full Text] [Related]
63. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
64. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract][Full Text] [Related]
65. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
66. [Detection of cytoplasmic antigens by flow cytometry and its implication for leukemia immunophenotyping].
Liu YR; Yu H; Chang Y; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):17-21. PubMed ID: 12513830
[TBL] [Abstract][Full Text] [Related]
67. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
68. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
Hicks MJ; Grogan TM; Fielder K; Spier CM
Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
[TBL] [Abstract][Full Text] [Related]
69. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
[TBL] [Abstract][Full Text] [Related]
70. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
Shokri F; Mageed RA; Richardson P; Jefferis R
Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
[TBL] [Abstract][Full Text] [Related]
71. [Diagnosis of chronic lymphoid leukemia (an immunomorphological study)].
Takhaev ZV; Probatova NA; Tupitsyn NN; Sholokhova EN; Osmanova DSh
Arkh Patol; 2002; 64(5):21-5. PubMed ID: 12575536
[TBL] [Abstract][Full Text] [Related]
72. Simultaneous expression of CD13, CD22 and CD25 is related to the expression of Fc epsilon R1 in non-lymphoid leukemia.
Sato N; Kishi K; Toba K; Watanabe K; Itoh H; Narita M; Takahashi M; Aizawa Y
Leuk Res; 2004 Jul; 28(7):691-8. PubMed ID: 15158090
[TBL] [Abstract][Full Text] [Related]
73. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
[TBL] [Abstract][Full Text] [Related]
74. Immunophenotyping of mature B-cell non Hodgkin lymphoma involving bone marrow and peripheral blood: critical analysis and insights gained at a tertiary care cancer hospital.
Gujral S; Polampalli SN; Badrinath Y; Kumar A; Subramanian PG; Nair R; Gupta S; Sengar M; Nair C
Leuk Lymphoma; 2009 Aug; 50(8):1290-300. PubMed ID: 19811331
[TBL] [Abstract][Full Text] [Related]
75. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
Moccia F; Casti P; Morra L
Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
[TBL] [Abstract][Full Text] [Related]
76. Hairy cell leukemia variant: fact or fiction.
Cessna MH; Hartung L; Tripp S; Perkins SL; Bahler DW
Am J Clin Pathol; 2005 Jan; 123(1):132-8. PubMed ID: 15762289
[TBL] [Abstract][Full Text] [Related]
77. Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia.
Ikematsu W; Ikematsu H; Okamura S; Otsuka T; Harada M; Niho Y
Blood; 1994 May; 83(9):2602-10. PubMed ID: 7513207
[TBL] [Abstract][Full Text] [Related]
78. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
79. Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease.
Escribano L; Orfao A; Villarrubia J; Cerveró C; Velasco JL; Martín F; San Miguel JF; Navarro JL
Br J Haematol; 1995 Dec; 91(4):941-3. PubMed ID: 8547146
[TBL] [Abstract][Full Text] [Related]
80. Hairy cell leukemia: its place among the chronic B cell leukemias.
Jansen J; den Ottolander GJ; Schuit HR; Waayer JL; Hijmans W
Semin Oncol; 1984 Dec; 11(4):386-93. PubMed ID: 6334366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
